SPDR Biotech ETF (XBI)

Overview News Price History Option Chain Discussions Forecast Stock Split Dividend History

SPDR Biotech ETF stock is currently priced at $82.83, with a 24-hour trading volume of 13.77M. It has seen a -0.78% decreased in the last 24 hours and a -11.74% declined in the past month. The chart indicates a potential bearish trend, as the stock is below the $83.93 pivot point. If it approaches the $82.37 support level, significant changes may occur.

SPDR Biotech ETF Stock (XBI) Financials Data

There is no financial data for SPDR Biotech ETF (XBI). Check out other stocks for more information.

SPDR Biotech ETF Stock (XBI) Latest News

Zacks Investment Ideas feature highlights: SPDR S&P Biotech ETF, iShares Biotech ETF, Viking Therapeutics and Madrigal Pharmaceuticals

Zacks Investment Research

Should You Invest in the First Trust NYSE Arca Biotechnology ETF (FBT)?

Zacks Investment Research

3 Top ETFs I Plan to Buy in April

The Motley Fool

The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the S&P Biotechnology Select Industry Index derived from the biotechnology segment of a U.S. total market composite index. In seeking to track the performance of the S&P Biotechnology Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the biotechnology segment of the S&P Total Market Index ("S&P TMI"). The fund is non-diversified.